Metrics to compare | 002872 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002872PeersSector | |
|---|---|---|---|---|
P/E Ratio | −46.1x | −14.4x | −0.4x | |
PEG Ratio | −0.96 | 0.13 | 0.00 | |
Price/Book | 1.0x | 2.0x | 2.6x | |
Price / LTM Sales | 3.8x | 5.3x | 3.1x | |
Upside (Analyst Target) | - | 31.8% | 54.8% | |
Fair Value Upside | Unlock | −17.3% | 7.6% | Unlock |
Tiansheng Pharmaceutical Group Co., Ltd. engages in pharmaceutical manufacturing and circulation activities. The company offers pediatric cough granules, erythromycin enteric-coated capsules, yinshen tongluo capsules, yanshen jianwei capsules, and sodium chloride injection products. It provides products in various categories, including respiratory, cardiovascular and cerebrovascular, urinary system, pediatrics, digestive, gynecological, orthopedic, cardiology, diabetes, anesthetic, oncology, hepatobiliary, hematological, surgical, and others. In addition, it provides traditional Chinese medicines and glucose injection. Tiansheng Pharmaceutical Group Co., Ltd. was founded in 2001 and is headquartered in Chongqing, China.